scholarly journals Effect of Fixed‐Dose ACE‐Inhibitor/Calcium Channel Blocker Combination Therapy vs. ACE‐Inhibitor Monotherapy on Arterial Compliance in Hypertensive Patients With Type 2 Diabetes

2005 ◽  
Vol 8 (2) ◽  
pp. 87-92 ◽  
Author(s):  
Nathaniel Winer ◽  
Amy Folker ◽  
Julie A. Murphy ◽  
Elena Hung ◽  
Mara Bard ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Calcium Channel ◽  
Calcium Channel Blocker ◽  
Ace Inhibitor ◽  
Channel Blocker ◽  
Arterial Compliance ◽  
Fixed Dose ◽  
Hypertensive Patients

scholarly journals Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis

2015 ◽  
Vol 17 (3) ◽  
pp. 193-199 ◽  
Author(s):  
Stefano F. Rimoldi ◽  
Franz H. Messerli ◽  
Patricia Chavez ◽  
Giulio G. Stefanini ◽  
Urs Scherrer
Keyword(s):  
Combination Therapy ◽  
Calcium Channel ◽  
Calcium Channel Blocker ◽  
Channel Blocker ◽  
Meta Analysis ◽  
Efficacy And Safety ◽  
Hypertensive Patients

scholarly journals Calcium Channel Blocker, Azelnidipine, Reduces Lipid Hydroperoxides in Patients with Type 2 Diabetes Independent of Blood Pressure

2007 ◽  
Vol 54 (5) ◽  
pp. 805-811 ◽  
Author(s):  
Chie OHMURA ◽  
Hirotaka WATADA ◽  
Tomoaki SHIMIZU ◽  
Ken SAKAI ◽  
Hiroshi UCHINO ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Calcium Channel ◽  
Calcium Channel Blocker ◽  
Channel Blocker ◽  
Lipid Hydroperoxides
Sign in / Sign up

Export Citation Format

Share Document